INMD News & Events

Yair Malca has stepped down from his role as CFO, effective May 5. To support a smooth transition, Malca will remain engaged with the company in a consulting capacity for at least six months. The company announced that Dr. Michael Anghel has resigned from the company's Board of Directors, effective May 5. His decision was not related to any disagreements with the company's management, Board, or operations.

Reports Q1 revenue $82.02M, consensus $79.86M. "While the macroeconomic environment remains challenging, our total revenue this quarter reached our expectations, however our profitability was lower than expected," said Moshe Mizrahy, Chief Executive Officer of InMode. "We are continuing to re-shape our organization in North America and in Europe by enhancing our sales and management teams. While the demand in the aesthetics market may be deferred, it will not be diminished, and we believe we are well positioned for its return."

Sees FY26 revenue $365M-$375M, consensus $370.04M. Non-GAAP gross margin between 74%-76%.

InMode announced that its Board of Directors has authorized a new share repurchase program for up to approximately 10% of the company's total shares outstanding, representing approximately 6.38M ordinary shares. In 2025, the company repurchased approximately $127.4M of its outstanding ordinary shares through share repurchase programs. Despite a challenging macroeconomic environment, the company continues to generate strong cash flow and believes that repurchasing shares at its current valuation represents an attractive use of capital.